US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Vaxcyte, Inc.

59.46

+0.56000.95%

Volume:1.23M

Turnover:72.08M

Market Cap:8.85B

PE:-7.77

High:60.20

Open:59.47

Low:58.22

Close:58.90

52wk High:65.00

52wk Low:30.81

Shares:148.81M

Float Shares:136.00M

Volume Ratio:1.42

T/O Rate:0.90%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.6496

EPS(LYR):-5.6333

ROE:-36.51%

ROA:-22.61%

PB:3.21

PE(LYR):-10.56

Loading ...

Overview Company News Filings

Vaxcyte Doses First Participant in Phase 1 Study Evaluating Vax-a1 for the Prevention of Disease Caused by Group a Streptococcus in Healthy Adults

THOMSON REUTERS

S&P 500 Futures Climb In Premarket Trading; MDA Space, ViaSat Lead

Vaxcyte Down Over 10%, On Track for Largest Percent Decrease Since May 2025 -- Data Talk

Analysts Have Conflicting Sentiments on These Healthcare Companies: Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmaceuticals (ACAD)

Vaxcyte Inc reports results for the quarter ended December 31 - Earnings Summary

Vaxcyte Q1 EPS $(2.30) Misses $(1.82) Estimate

Benzinga Earnings

Vaxcyte Q1 net loss widens to $320.6 million; R&D expenses jump to $312.8 million

BRIEF-Vaxcyte Q1 Operating Expenses USD 345.85 Million

Vaxcyte COO Jim Wassil disposes of USD 127,869 common shares

Vaxcyte announces upcoming annual shareholder meeting

Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and Vaxcyte (PCVX)

Vaxcyte SVP Finance Elvia Cowan disposes of USD 180,000 common shares

Vaxcyte to present at Needham Virtual Healthcare Conference fireside chat

Vaxcyte (PCVX) Valuation Check As VAX-31 Phase 3 OPUS Trials Reach Full Enrollment

Simply Wall St.

Vaxcyte COO Jim Wassil disposes of common shares worth $0.1 million

Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer

Vaxcyte completes enrollment in OPUS-1 and OPUS-2 Phase 3 trials of VAX-31 in about 5,300 adults

Vaxcyte Inc - Opus-3 Phase 3 Results Expected in First Half of 2027

THOMSON REUTERS

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

Will VAX-31’s Phase 3 OPUS Progress and Broader Serotype Coverage Change Vaxcyte’s (PCVX) Narrative

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/PCVX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PCVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","market":"US","secType":"STK","nameCN":"Vaxcyte, Inc.","latestPrice":59.46,"timestamp":1789153175700,"preClose":58.9,"halted":0,"volume":1227434,"delay":0,"changeRate":0.009507640067911754,"floatShares":136000000,"shares":148805278,"eps":-7.649608,"marketStatus":"Trading","change":0.56,"latestTime":"09-11 14:59:38 EDT","open":59.47,"high":60.2,"low":58.22,"amount":72081373.418236,"amplitude":0.033616,"askPrice":59.54,"askSize":50,"bidPrice":59.41,"bidSize":31,"shortable":3,"etf":0,"ttmEps":-7.649608,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789156800000},"marketStatusCode":2,"adr":0,"listingDate":1591934400000,"exchange":"NASDAQ","adjPreClose":58.9,"preHourTrading":{"tag":"盘前","latestPrice":59.05,"preClose":58.9,"latestTime":"09:29 EDT","volume":14340,"amount":847038.4612199999,"timestamp":1789133398999,"change":0.15,"changeRate":0.002547,"amplitude":0.030319},"postHourTrading":{"tag":"盘后","latestPrice":58.9,"preClose":58.9,"latestTime":"19:30 EDT","volume":20284,"amount":1194727.77,"timestamp":1789083008392,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.421173,"impliedVol":0.6585,"impliedVolPercentile":0.8127},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCVX\",,,,,undefined,":{"symbol":"PCVX","floatShares":136000000,"roa":"-22.61%","roe":"-36.51%","lyrEps":-5.633263,"volumeRatio":1.421173,"shares":148805278,"dividePrice":0,"high":60.2,"amplitude":0.033616,"preClose":58.9,"low":58.22,"week52Low":30.81,"pbRate":"3.21","week52High":65,"institutionHeld":0,"latestPrice":59.46,"committee":-0.234568,"eps":-7.649608,"divideRate":0,"volume":1227434,"delay":0,"ttmEps":-7.649608,"open":59.47,"prevYearClose":46.14,"prevWeekClose":61.16,"prevMonthClose":60.74,"prevQuarterClose":58.13,"fiveDayClose":61.17,"twentyDayClose":58.86,"sixtyDayClose":49.31},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"PCVX","fiscalQuarterEnding":"2026/06","expectedEps":-1.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-1.97},{"market":"US","date":"2026-05-06","symbol":"PCVX","fiscalQuarterEnding":"2026/03","expectedEps":-1.86,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-2.3},{"market":"US","date":"2026-02-24","symbol":"PCVX","fiscalQuarterEnding":"2025/12","expectedEps":-1.46,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771909200000,"reportTimeType":"post","actualEps":-1.8},{"market":"US","date":"2025-11-04","symbol":"PCVX","fiscalQuarterEnding":"2025/09","expectedEps":-1.27,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":-1.56},{"market":"US","date":"2025-08-06","symbol":"PCVX","fiscalQuarterEnding":"2025/06","expectedEps":-1.12,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-1.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4545,"buy":0.4545,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4545,"analysts":11,"updateTime":1769832000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PCVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PCVX","date":"2026-09-10","current":-7.699741,"percent":0.913043,"low":-29.340195,"twenty":-19.835244,"median":-14.098831,"eighty":-9.361951,"high":-6.929024,"avg":-14.931703,"sd":5.445666,"marketCap":8855402093},"quantilePoints":[{"date":"2021-09-17","current":-15.273621,"twenty":-30.399459,"median":-16.002108,"eighty":-13.545554,"marketCap":1323520369},{"date":"2021-09-24","current":-15.526575,"twenty":-30.296,"median":-15.971408,"eighty":-13.571461,"marketCap":1345439870},{"date":"2021-10-01","current":-15.797598,"twenty":-30.252261,"median":-15.938491,"eighty":-13.585031,"marketCap":1368925050},{"date":"2021-10-08","current":-14.544872,"twenty":-30.181073,"median":-15.881916,"eighty":-13.619573,"marketCap":1260371329},{"date":"2021-10-15","current":-14.701463,"twenty":-30.038168,"median":-15.83959,"eighty":-13.634377,"marketCap":1273940544},{"date":"2021-10-22","current":-13.6776,"twenty":-29.986874,"median":-15.836525,"eighty":-13.619573,"marketCap":1185218753},{"date":"2021-10-29","current":-14.093168,"twenty":-29.919091,"median":-15.822921,"eighty":-13.619573,"marketCap":1221229362},{"date":"2021-11-05","current":-15.243508,"twenty":-29.833872,"median":-15.797598,"eighty":-13.623951,"marketCap":1320910904},{"date":"2021-11-12","current":-15.134436,"twenty":-29.751073,"median":-15.774414,"eighty":-13.643873,"marketCap":1396166847},{"date":"2021-11-19","current":-12.994444,"twenty":-29.640151,"median":-15.762952,"eighty":-13.643873,"marketCap":1198750438},{"date":"2021-11-26","current":-11.363701,"twenty":-29.615934,"median":-15.755439,"eighty":-13.576395,"marketCap":1048312800},{"date":"2021-12-03","current":-11.054718,"twenty":-29.492837,"median":-15.662087,"eighty":-13.502376,"marketCap":1019808827},{"date":"2021-12-10","current":-12.439419,"twenty":-29.474665,"median":-15.610894,"eighty":-13.409852,"marketCap":1147548856},{"date":"2021-12-17","current":-12.679739,"twenty":-29.293034,"median":-15.552798,"eighty":-13.261813,"marketCap":1169718613},{"date":"2021-12-23","current":-13.82412,"twenty":-29.268816,"median":-15.502485,"eighty":-13.260579,"marketCap":1275288885},{"date":"2021-12-31","current":-13.612409,"twenty":-29.21926,"median":-15.450268,"eighty":-13.25441,"marketCap":1255758385},{"date":"2022-01-07","current":-13.612409,"twenty":-29.141782,"median":-15.412813,"eighty":-13.260579,"marketCap":1255758385},{"date":"2022-01-14","current":-11.644212,"twenty":-29.049569,"median":-15.345894,"eighty":-13.248242,"marketCap":1074190192},{"date":"2022-01-21","current":-10.46361,"twenty":-28.988298,"median":-15.279644,"eighty":-13.177704,"marketCap":965278474},{"date":"2022-01-28","current":-10.685347,"twenty":-28.867611,"median":-15.231462,"eighty":-13.055331,"marketCap":985733974},{"date":"2022-02-04","current":-10.739283,"twenty":-28.373067,"median":-15.186632,"eighty":-12.971556,"marketCap":990709637},{"date":"2022-02-11","current":-11.841978,"twenty":-27.884642,"median":-15.154572,"eighty":-12.789242,"marketCap":1092434287},{"date":"2022-02-18","current":-12.213538,"twenty":-27.569868,"median":-15.134436,"eighty":-12.66337,"marketCap":1126711071},{"date":"2022-02-25","current":-13.543962,"twenty":-27.447762,"median":-15.081457,"eighty":-12.60844,"marketCap":1249444073},{"date":"2022-03-04","current":-12.902121,"twenty":-27.407317,"median":-15.056803,"eighty":-12.655185,"marketCap":1291205520},{"date":"2022-03-11","current":-13.667358,"twenty":-27.190856,"median":-15.039487,"eighty":-12.697912,"marketCap":1367788141},{"date":"2022-03-18","current":-14.629531,"twenty":-26.912591,"median":-15.031927,"eighty":-12.729886,"marketCap":1464079526},{"date":"2022-03-25","current":-13.481675,"twenty":-26.806708,"median":-15.008832,"eighty":-12.75445,"marketCap":1349205593},{"date":"2022-04-01","current":-13.397274,"twenty":-26.56186,"median":-15.002599,"eighty":-12.786391,"marketCap":1340758981},{"date":"2022-04-08","current":-14.438221,"twenty":-26.252858,"median":-14.954417,"eighty":-12.801505,"marketCap":1444933870},{"date":"2022-04-14","current":-13.802399,"twenty":-26.169603,"median":-14.89419,"eighty":-12.812618,"marketCap":1381302722},{"date":"2022-04-22","current":-14.501863,"twenty":-26.054435,"median":-14.847747,"eighty":-12.834599,"marketCap":1451302975},{"date":"2022-04-29","current":-14.043604,"twenty":-25.893476,"median":-14.832093,"eighty":-12.903035,"marketCap":1405441800},{"date":"2022-05-06","current":-14.078409,"twenty":-25.749169,"median":-14.8193,"eighty":-12.912799,"marketCap":1408924928},{"date":"2022-05-13","current":-11.643665,"twenty":-25.696441,"median":-14.803884,"eighty":-12.798225,"marketCap":1372124372},{"date":"2022-05-20","current":-12.974793,"twenty":-25.63955,"median":-14.78197,"eighty":-12.727529,"marketCap":1528988570},{"date":"2022-05-27","current":-12.910464,"twenty":-25.529933,"median":-14.739625,"eighty":-12.727529,"marketCap":1521407772},{"date":"2022-06-03","current":-10.83707,"twenty":-25.468879,"median":-14.701463,"eighty":-12.638816,"marketCap":1277072833},{"date":"2022-06-10","current":-9.322849,"twenty":-25.378687,"median":-14.632372,"eighty":-12.529434,"marketCap":1098632519},{"date":"2022-06-17","current":-9.990888,"twenty":-25.323184,"median":-14.567395,"eighty":-12.411304,"marketCap":1177356187},{"date":"2022-06-24","current":-9.649446,"twenty":-25.295433,"median":-14.559871,"eighty":-12.356612,"marketCap":1137119646},{"date":"2022-07-01","current":-10.733153,"twenty":-25.027632,"median":-14.544872,"eighty":-12.280659,"marketCap":1264826929},{"date":"2022-07-08","current":-11.802015,"twenty":-24.945765,"median":-14.531772,"eighty":-12.208936,"marketCap":1390784797},{"date":"2022-07-15","current":-12.316652,"twenty":-23.952679,"median":-14.512216,"eighty":-12.136983,"marketCap":1451431178},{"date":"2022-07-22","current":-11.287377,"twenty":-22.944874,"median":-14.465518,"eighty":-12.125268,"marketCap":1330138416},{"date":"2022-07-29","current":-11.420985,"twenty":-22.588047,"median":-14.443856,"eighty":-12.103448,"marketCap":1345883150},{"date":"2022-08-05","current":-12.831289,"twenty":-22.429865,"median":-14.436004,"eighty":-12.081262,"marketCap":1512077560},{"date":"2022-08-12","current":-10.957188,"twenty":-21.819211,"median":-14.406349,"eighty":-11.987006,"marketCap":1563546932},{"date":"2022-08-19","current":-10.807545,"twenty":-21.413336,"median":-14.344728,"eighty":-11.893983,"marketCap":1542193484},{"date":"2022-08-26","current":-11.55576,"twenty":-21.328727,"median":-14.308806,"eighty":-11.856598,"marketCap":1648960725},{"date":"2022-09-02","current":-10.965502,"twenty":-21.257607,"median":-14.253853,"eighty":-11.805991,"marketCap":1564733234},{"date":"2022-09-09","current":-11.759441,"twenty":-21.228177,"median":-14.197019,"eighty":-11.782001,"marketCap":1678025140},{"date":"2022-09-16","current":-10.861583,"twenty":-21.051603,"median":-14.162382,"eighty":-11.765767,"marketCap":1549904451},{"date":"2022-09-23","current":-10.325363,"twenty":-20.642048,"median":-14.149216,"eighty":-11.72881,"marketCap":1473387928},{"date":"2022-09-30","current":-9.976196,"twenty":-20.374734,"median":-14.130616,"eighty":-11.651023,"marketCap":1423563216},{"date":"2022-10-07","current":-10.00945,"twenty":-20.25334,"median":-14.108764,"eighty":-11.612104,"marketCap":1428308426},{"date":"2022-10-14","current":-10.208974,"twenty":-20.041205,"median":-14.087145,"eighty":-11.550385,"marketCap":1456779691},{"date":"2022-10-21","current":-8.554588,"twenty":-19.925941,"median":-14.050563,"eighty":-11.479299,"marketCap":1220705457},{"date":"2022-10-28","current":-23.436216,"twenty":-20.25334,"median":-14.078409,"eighty":-11.519454,"marketCap":3344254210},{"date":"2022-11-04","current":-23.236229,"twenty":-21.228177,"median":-14.098831,"eighty":-11.528532,"marketCap":3315716985},{"date":"2022-11-11","current":-20.162877,"twenty":-21.051603,"median":-14.115937,"eighty":-11.5396,"marketCap":3508300306},{"date":"2022-11-18","current":-19.99039,"twenty":-20.642048,"median":-14.139963,"eighty":-11.550385,"marketCap":3478287831},{"date":"2022-11-25","current":-19.972233,"twenty":-20.383318,"median":-14.156214,"eighty":-11.558496,"marketCap":3475128624},{"date":"2022-12-02","current":-20.385295,"twenty":-20.609529,"median":-14.168551,"eighty":-11.575016,"marketCap":3547000602},{"date":"2022-12-09","current":-19.241431,"twenty":-20.426561,"median":-14.229892,"eighty":-11.597521,"marketCap":3347970508},{"date":"2022-12-16","current":-20.789279,"twenty":-20.651289,"median":-14.285748,"eighty":-11.6052,"marketCap":3617292976},{"date":"2022-12-23","current":-21.184185,"twenty":-20.782016,"median":-14.325872,"eighty":-11.6332,"marketCap":3686005747},{"date":"2022-12-30","current":-21.765195,"twenty":-20.907297,"median":-14.359697,"eighty":-11.634738,"marketCap":3787100398},{"date":"2023-01-06","current":-21.175106,"twenty":-21.113374,"median":-14.412372,"eighty":-11.64188,"marketCap":3684426143},{"date":"2023-01-13","current":-20.25366,"twenty":-20.996264,"median":-14.438221,"eighty":-11.644103,"marketCap":3524096345},{"date":"2023-01-20","current":-20.471539,"twenty":-20.932716,"median":-14.443856,"eighty":-11.654429,"marketCap":3562006839},{"date":"2023-01-27","current":-20.957227,"twenty":-21.021683,"median":-14.465518,"eighty":-11.668106,"marketCap":3646515649},{"date":"2023-02-03","current":-20.539626,"twenty":-20.962674,"median":-14.501863,"eighty":-11.693283,"marketCap":3573853869},{"date":"2023-02-10","current":-19.858755,"twenty":-20.927269,"median":-14.524498,"eighty":-11.719479,"marketCap":3455383575},{"date":"2023-02-17","current":-20.072094,"twenty":-20.907297,"median":-14.544872,"eighty":-11.729321,"marketCap":3492504267},{"date":"2023-02-24","current":-18.92823,"twenty":-20.885509,"median":-14.550984,"eighty":-11.733669,"marketCap":3293474173},{"date":"2023-03-03","current":-15.234288,"twenty":-20.849196,"median":-14.56482,"eighty":-11.744206,"marketCap":3404634746},{"date":"2023-03-10","current":-13.543976,"twenty":-20.829775,"median":-14.567395,"eighty":-11.755294,"marketCap":3026875555},{"date":"2023-03-17","current":-13.461609,"twenty":-20.800999,"median":-14.555428,"eighty":-11.765767,"marketCap":3008467797},{"date":"2023-03-24","current":-13.551139,"twenty":-20.774754,"median":-14.544872,"eighty":-11.782001,"marketCap":3028476229},{"date":"2023-03-31","current":-13.422217,"twenty":-20.713022,"median":-14.524498,"eighty":-11.796077,"marketCap":2999664087},{"date":"2023-04-06","current":-13.475934,"twenty":-20.653105,"median":-14.50704,"eighty":-11.802778,"marketCap":3011669147},{"date":"2023-04-14","current":-13.074843,"twenty":-20.651289,"median":-14.481561,"eighty":-11.805884,"marketCap":2922031372},{"date":"2023-04-21","current":-18.52965,"twenty":-20.644026,"median":-14.496144,"eighty":-11.808405,"marketCap":4141098868},{"date":"2023-04-28","current":-17.350338,"twenty":-20.637671,"median":-14.522192,"eighty":-11.817795,"marketCap":3877540192},{"date":"2023-05-05","current":-20.292744,"twenty":-20.608621,"median":-14.540806,"eighty":-11.820768,"marketCap":4535123986},{"date":"2023-05-12","current":-18.764855,"twenty":-20.608621,"median":-14.550984,"eighty":-11.830425,"marketCap":4596657665},{"date":"2023-05-19","current":-18.602803,"twenty":-20.594096,"median":-14.562246,"eighty":-11.831705,"marketCap":4556961197},{"date":"2023-05-25","current":-19.486465,"twenty":-20.588649,"median":-14.567395,"eighty":-11.837869,"marketCap":4773423882},{"date":"2023-06-02","current":-19.241641,"twenty":-20.566861,"median":-14.631091,"eighty":-11.848868,"marketCap":4713451537},{"date":"2023-06-09","current":-19.494115,"twenty":-20.535087,"median":-14.653628,"eighty":-11.860631,"marketCap":4775298018},{"date":"2023-06-16","current":-19.94551,"twenty":-20.51693,"median":-14.700243,"eighty":-11.866344,"marketCap":4885872030},{"date":"2023-06-23","current":-20.683807,"twenty":-20.530548,"median":-14.717194,"eighty":-11.866918,"marketCap":5066726135},{"date":"2023-06-30","current":-18.556898,"twenty":-20.521469,"median":-14.735995,"eighty":-11.867493,"marketCap":4545716382},{"date":"2023-07-07","current":-17.986917,"twenty":-20.50876,"median":-14.751068,"eighty":-11.869888,"marketCap":4406093265},{"date":"2023-07-14","current":-18.530121,"twenty":-20.492419,"median":-14.775826,"eighty":-11.883169,"marketCap":4539156907},{"date":"2023-07-21","current":-18.308249,"twenty":-20.476986,"median":-14.795999,"eighty":-11.893983,"marketCap":4484806969},{"date":"2023-07-28","current":-17.684713,"twenty":-20.449751,"median":-14.806507,"eighty":-11.917488,"marketCap":4332064901},{"date":"2023-08-04","current":-18.675485,"twenty":-20.429779,"median":-14.847747,"eighty":-11.938838,"marketCap":4574765487},{"date":"2023-08-11","current":-16.822179,"twenty":-20.409807,"median":-14.877903,"eighty":-11.965282,"marketCap":4453974775},{"date":"2023-08-18","current":-16.808001,"twenty":-20.39619,"median":-14.922726,"eighty":-11.987006,"marketCap":4450220898},{"date":"2023-08-25","current":-17.499178,"twenty":-20.39289,"median":-14.955882,"eighty":-12.021492,"marketCap":4633222391},{"date":"2023-09-01","current":-18.403025,"twenty":-20.387937,"median":-15.002599,"eighty":-12.049146,"marketCap":4872532034},{"date":"2023-09-08","current":-17.65868,"twenty":-20.370771,"median":-15.005716,"eighty":-12.05623,"marketCap":4675453504},{"date":"2023-09-15","current":-18.254156,"twenty":-20.34457,"median":-15.02393,"eighty":-12.07384,"marketCap":4833116328},{"date":"2023-09-22","current":-18.498726,"twenty":-20.336915,"median":-15.038325,"eighty":-12.101,"marketCap":4897870702},{"date":"2023-09-29","current":-17.793371,"twenty":-20.329918,"median":-15.05078,"eighty":-12.110314,"marketCap":4711115333},{"date":"2023-10-05","current":-16.981682,"twenty":-20.318417,"median":-15.056803,"eighty":-12.11436,"marketCap":4496205889},{"date":"2023-10-13","current":-16.074291,"twenty":-20.302625,"median":-15.087198,"eighty":-12.118714,"marketCap":4255957776},{"date":"2023-10-20","current":-16.481908,"twenty":-20.286743,"median":-15.148339,"eighty":-12.120899,"marketCap":4363881733},{"date":"2023-10-27","current":-17.109284,"twenty":-20.27474,"median":-15.149846,"eighty":-12.125268,"marketCap":4529990780},{"date":"2023-11-03","current":-16.942692,"twenty":-20.257291,"median":-15.15932,"eighty":-12.136983,"marketCap":4485882728},{"date":"2023-11-10","current":-15.261986,"twenty":-20.237319,"median":-15.186632,"eighty":-12.142826,"marketCap":4571193788},{"date":"2023-11-17","current":-15.913257,"twenty":-20.193743,"median":-15.226852,"eighty":-12.158302,"marketCap":4766259301},{"date":"2023-11-24","current":-15.671811,"twenty":-20.168324,"median":-15.249734,"eighty":-12.181733,"marketCap":4693942330},{"date":"2023-12-01","current":-16.446982,"twenty":-20.146536,"median":-15.273621,"eighty":-12.206635,"marketCap":4926117868},{"date":"2023-12-08","current":-18.038626,"twenty":-20.120209,"median":-15.310702,"eighty":-12.223784,"marketCap":5402838953},{"date":"2023-12-15","current":-19.249037,"twenty":-20.114441,"median":-15.345894,"eighty":-12.244421,"marketCap":5765375346},{"date":"2023-12-22","current":-18.858274,"twenty":-20.094761,"median":-15.397427,"eighty":-12.255986,"marketCap":5648336038},{"date":"2023-12-29","current":-20.113163,"twenty":-20.109873,"median":-15.413482,"eighty":-12.261481,"marketCap":6024193978},{"date":"2024-01-05","current":-20.440387,"twenty":-20.111189,"median":-15.447202,"eighty":-12.270831,"marketCap":6122202505},{"date":"2024-01-12","current":-19.061598,"twenty":-20.087206,"median":-15.502485,"eighty":-12.282097,"marketCap":5709234540},{"date":"2024-01-19","current":-19.32846,"twenty":-20.064832,"median":-15.526575,"eighty":-12.296687,"marketCap":5789163823},{"date":"2024-01-26","current":-20.141755,"twenty":-20.103564,"median":-15.604871,"eighty":-12.314783,"marketCap":6032757830},{"date":"2024-02-02","current":-26.753532,"twenty":-20.133863,"median":-15.653053,"eighty":-12.324561,"marketCap":8013084121},{"date":"2024-02-09","current":-26.696296,"twenty":-20.242766,"median":-15.671811,"eighty":-12.343291,"marketCap":7995941244},{"date":"2024-02-16","current":-27.009566,"twenty":-20.315086,"median":-15.741703,"eighty":-12.355101,"marketCap":8089770067},{"date":"2024-02-23","current":-26.599075,"twenty":-20.346777,"median":-15.756821,"eighty":-12.358131,"marketCap":7966821955},{"date":"2024-03-01","current":-19.791455,"twenty":-20.39058,"median":-15.767484,"eighty":-12.362433,"marketCap":7961429494},{"date":"2024-03-08","current":-19.338793,"twenty":-20.378033,"median":-15.787476,"eighty":-12.370073,"marketCap":7779338704},{"date":"2024-03-15","current":-18.670451,"twenty":-20.346777,"median":-15.797598,"eighty":-12.386838,"marketCap":7510487534},{"date":"2024-03-22","current":-18.228483,"twenty":-20.337432,"median":-15.827712,"eighty":-12.411509,"marketCap":7332698857},{"date":"2024-03-28","current":-18.460246,"twenty":-20.335365,"median":-15.836525,"eighty":-12.412327,"marketCap":7425929505},{"date":"2024-04-05","current":-17.075054,"twenty":-20.321747,"median":-15.83959,"eighty":-12.439419,"marketCap":6868713772},{"date":"2024-04-12","current":-17.471208,"twenty":-20.305095,"median":-15.881916,"eighty":-12.458883,"marketCap":7028073135},{"date":"2024-04-19","current":-16.389647,"twenty":-20.292744,"median":-15.911669,"eighty":-12.479472,"marketCap":6592997737},{"date":"2024-04-26","current":-16.238241,"twenty":-20.262738,"median":-15.930098,"eighty":-12.504692,"marketCap":6532092446},{"date":"2024-05-03","current":-17.452189,"twenty":-20.25366,"median":-15.962149,"eighty":-12.529434,"marketCap":7020422368},{"date":"2024-05-10","current":-16.330835,"twenty":-20.226425,"median":-15.977539,"eighty":-12.570574,"marketCap":7133700477},{"date":"2024-05-17","current":-18.791543,"twenty":-20.171955,"median":-16.02345,"eighty":-12.576745,"marketCap":8208596934},{"date":"2024-05-24","current":-17.252355,"twenty":-20.162877,"median":-16.044981,"eighty":-12.588189,"marketCap":7536242672},{"date":"2024-05-31","current":-17.486471,"twenty":-20.145979,"median":-16.069505,"eighty":-12.628691,"marketCap":7638510149},{"date":"2024-06-07","current":-18.059308,"twenty":-20.138199,"median":-16.100696,"eighty":-12.670073,"marketCap":7888739081},{"date":"2024-06-14","current":-18.432897,"twenty":-20.128139,"median":-16.153211,"eighty":-12.677887,"marketCap":8051931863},{"date":"2024-06-21","current":-18.121573,"twenty":-20.120209,"median":-16.193449,"eighty":-12.678628,"marketCap":7915937878},{"date":"2024-06-28","current":-19.618421,"twenty":-20.118394,"median":-16.224679,"eighty":-12.679369,"marketCap":8569796958},{"date":"2024-07-05","current":-18.993281,"twenty":-20.114892,"median":-16.24076,"eighty":-12.706999,"marketCap":8296721036},{"date":"2024-07-12","current":-20.412921,"twenty":-20.128139,"median":-16.30313,"eighty":-12.732244,"marketCap":8916853608},{"date":"2024-07-15","current":-20.520016,"twenty":-20.138199,"median":-16.303907,"eighty":-12.734601,"marketCap":8963635539},{"date":"2024-08-02","current":-19.57359,"twenty":-20.13731,"median":-16.304683,"eighty":-12.736958,"marketCap":8550213824},{"date":"2024-08-09","current":-16.530842,"twenty":-20.122025,"median":-16.304683,"eighty":-12.780687,"marketCap":8218936172},{"date":"2024-08-16","current":-17.608355,"twenty":-20.117486,"median":-16.330835,"eighty":-12.794946,"marketCap":8754662593},{"date":"2024-08-23","current":-17.54101,"twenty":-20.113163,"median":-16.355854,"eighty":-12.79665,"marketCap":8721179691},{"date":"2024-08-30","current":-17.796919,"twenty":-20.109873,"median":-16.382189,"eighty":-12.811343,"marketCap":8848414716},{"date":"2024-09-06","current":-25.164413,"twenty":-20.118394,"median":-16.416684,"eighty":-12.816444,"marketCap":12511444119},{"date":"2024-09-13","current":-28.394781,"twenty":-20.157687,"median":-16.444961,"eighty":-12.828575,"marketCap":14117544202},{"date":"2024-09-20","current":-29.138673,"twenty":-20.231872,"median":-16.459942,"eighty":-12.887955,"marketCap":14487398378},{"date":"2024-09-27","current":-27.725527,"twenty":-20.308425,"median":-16.491202,"eighty":-12.905778,"marketCap":13784799140},{"date":"2024-10-04","current":-27.635961,"twenty":-20.356246,"median":-16.541596,"eighty":-12.90971,"marketCap":13740268202},{"date":"2024-10-11","current":-27.765334,"twenty":-20.401715,"median":-16.572344,"eighty":-12.931873,"marketCap":13804590668},{"date":"2024-10-18","current":-28.762995,"twenty":-20.436258,"median":-16.616599,"eighty":-12.959362,"marketCap":14300615834},{"date":"2024-10-25","current":-27.944465,"twenty":-20.506036,"median":-16.648008,"eighty":-12.966906,"marketCap":13893652543},{"date":"2024-10-31","current":-26.399458,"twenty":-20.557783,"median":-16.667668,"eighty":-12.971839,"marketCap":13125493869},{"date":"2024-11-08","current":-25.214663,"twenty":-20.644026,"median":-16.733567,"eighty":-12.983254,"marketCap":12800173274},{"date":"2024-11-15","current":-22.754576,"twenty":-20.684289,"median":-16.791289,"eighty":-12.992224,"marketCap":11551315083},{"date":"2024-11-22","current":-21.701305,"twenty":-20.822787,"median":-16.813646,"eighty":-12.995724,"marketCap":11016624300},{"date":"2024-11-29","current":-23.162135,"twenty":-20.907297,"median":-16.822179,"eighty":-13.001558,"marketCap":11758211749},{"date":"2024-12-06","current":-22.10641,"twenty":-21.101995,"median":-16.843442,"eighty":-13.013917,"marketCap":11222274601},{"date":"2024-12-13","current":-21.573636,"twenty":-21.189632,"median":-16.875347,"eighty":-13.021971,"marketCap":10951813297},{"date":"2024-12-20","current":-21.166077,"twenty":-21.226278,"median":-16.929408,"eighty":-13.028697,"marketCap":10744916630},{"date":"2024-12-27","current":-21.060504,"twenty":-21.23055,"median":-16.99586,"eighty":-13.041117,"marketCap":10691322915},{"date":"2025-01-03","current":-20.451621,"twenty":-21.213463,"median":-17.04371,"eighty":-13.056938,"marketCap":10382224281},{"date":"2025-01-10","current":-19.901661,"twenty":-21.217735,"median":-17.069181,"eighty":-13.068397,"marketCap":10103038418},{"date":"2025-01-17","current":-21.563816,"twenty":-21.235455,"median":-17.105654,"eighty":-13.074127,"marketCap":10946827835},{"date":"2025-01-24","current":-22.090451,"twenty":-21.246134,"median":-17.110391,"eighty":-13.076047,"marketCap":11214173226},{"date":"2025-01-31","current":-22.575348,"twenty":-21.285242,"median":-17.144092,"eighty":-13.080045,"marketCap":11460330404},{"date":"2025-02-07","current":-21.854754,"twenty":-21.34285,"median":-17.212623,"eighty":-13.093733,"marketCap":11094522142},{"date":"2025-02-14","current":-20.5842,"twenty":-21.34285,"median":-17.248595,"eighty":-13.124157,"marketCap":10449528016},{"date":"2025-02-21","current":-20.247841,"twenty":-21.305793,"median":-17.268422,"eighty":-13.140798,"marketCap":10278775948},{"date":"2025-02-28","current":-20.59955,"twenty":-21.28584,"median":-17.296089,"eighty":-13.151072,"marketCap":9556687584},{"date":"2025-03-07","current":-20.763303,"twenty":-21.279088,"median":-17.346779,"eighty":-13.166601,"marketCap":9632656941},{"date":"2025-03-14","current":-20.266494,"twenty":-21.271161,"median":-17.38221,"eighty":-13.175744,"marketCap":9402173638},{"date":"2025-03-21","current":-20.666162,"twenty":-21.261605,"median":-17.434922,"eighty":-13.187616,"marketCap":9587590374},{"date":"2025-03-28","current":-19.642013,"twenty":-21.246879,"median":-17.48489,"eighty":-13.202598,"marketCap":9112459988},{"date":"2025-04-04","current":-8.481841,"twenty":-21.24317,"median":-17.461699,"eighty":-13.166601,"marketCap":3934955168},{"date":"2025-04-11","current":-7.782422,"twenty":-21.239771,"median":-17.384971,"eighty":-13.08988,"marketCap":3610475880},{"date":"2025-04-17","current":-8.082173,"twenty":-21.237354,"median":-17.363411,"eighty":-13.071978,"marketCap":3749538432},{"date":"2025-04-25","current":-9.578153,"twenty":-21.23055,"median":-17.338853,"eighty":-13.021611,"marketCap":4443563575},{"date":"2025-05-02","current":-9.79882,"twenty":-21.209423,"median":-17.273877,"eighty":-12.990005,"marketCap":4545937129},{"date":"2025-05-09","current":-7.961109,"twenty":-21.191447,"median":-17.258708,"eighty":-12.942759,"marketCap":4057180140},{"date":"2025-05-16","current":-7.821884,"twenty":-21.182369,"median":-17.225081,"eighty":-12.845455,"marketCap":3986227864},{"date":"2025-05-23","current":-8.593947,"twenty":-21.1733,"median":-17.165551,"eighty":-12.795287,"marketCap":4379690485},{"date":"2025-05-30","current":-8.302842,"twenty":-21.166077,"median":-17.133888,"eighty":-12.725172,"marketCap":4231335726},{"date":"2025-06-06","current":-8.809113,"twenty":-21.132441,"median":-17.109284,"eighty":-12.638816,"marketCap":4489344002},{"date":"2025-06-13","current":-8.723047,"twenty":-21.131367,"median":-17.105654,"eighty":-12.581323,"marketCap":4445482595},{"date":"2025-06-20","current":-8.454723,"twenty":-21.099418,"median":-17.04371,"eighty":-12.484516,"marketCap":4308738209},{"date":"2025-06-27","current":-8.323093,"twenty":-21.036935,"median":-16.897568,"eighty":-12.386838,"marketCap":4241656057},{"date":"2025-07-03","current":-8.416753,"twenty":-20.935584,"median":-16.843442,"eighty":-12.354346,"marketCap":4289387588},{"date":"2025-07-11","current":-9.173628,"twenty":-20.851011,"median":-16.810823,"eighty":-12.278742,"marketCap":4675109961},{"date":"2025-07-18","current":-9.459671,"twenty":-20.784084,"median":-16.720351,"eighty":-12.204334,"marketCap":4820884637},{"date":"2025-07-25","current":-9.173628,"twenty":-20.68477,"median":-16.635317,"eighty":-12.120899,"marketCap":4675109961},{"date":"2025-08-01","current":-8.593947,"twenty":-20.644026,"median":-16.553858,"eighty":-12.066419,"marketCap":4379690485},{"date":"2025-08-08","current":-7.116045,"twenty":-20.598459,"median":-16.480136,"eighty":-11.950749,"marketCap":3895998883},{"date":"2025-08-15","current":-7.452759,"twenty":-20.519399,"median":-16.437368,"eighty":-11.868483,"marketCap":4080348047},{"date":"2025-08-22","current":-7.566577,"twenty":-20.482433,"median":-16.366967,"eighty":-11.830425,"marketCap":4142663258},{"date":"2025-08-29","current":-7.296258,"twenty":-20.434352,"median":-16.309999,"eighty":-11.802778,"marketCap":3994664633},{"date":"2025-09-05","current":-7.623487,"twenty":-20.394374,"median":-16.243279,"eighty":-11.75253,"marketCap":4173820863},{"date":"2025-09-12","current":-7.839268,"twenty":-20.337432,"median":-16.175585,"eighty":-11.67955,"marketCap":4291960116},{"date":"2025-09-19","current":-7.727821,"twenty":-20.287494,"median":-16.074786,"eighty":-11.6332,"marketCap":4230943139},{"date":"2025-09-26","current":-7.621115,"twenty":-20.247841,"median":-16.038507,"eighty":-11.548594,"marketCap":4172522629},{"date":"2025-10-03","current":-9.515724,"twenty":-20.161579,"median":-15.967748,"eighty":-11.435788,"marketCap":5209811236},{"date":"2025-10-10","current":-9.956772,"twenty":-20.121117,"median":-15.919611,"eighty":-11.377135,"marketCap":5451282676},{"date":"2025-10-17","current":-10.336168,"twenty":-20.092195,"median":-15.848787,"eighty":-11.300594,"marketCap":5659000044},{"date":"2025-10-24","current":-9.864294,"twenty":-20.052985,"median":-15.830426,"eighty":-11.247666,"marketCap":5400651568},{"date":"2025-10-31","current":-10.61123,"twenty":-19.995479,"median":-15.795066,"eighty":-11.085574,"marketCap":5809595136},{"date":"2025-11-07","current":-8.308113,"twenty":-19.989732,"median":-15.765218,"eighty":-10.958851,"marketCap":5460100229},{"date":"2025-11-14","current":-9.072993,"twenty":-19.958021,"median":-15.674477,"eighty":-10.876553,"marketCap":5962780279},{"date":"2025-11-21","current":-9.495271,"twenty":-19.924444,"median":-15.629917,"eighty":-10.841973,"marketCap":6240301557},{"date":"2025-11-28","current":-9.881695,"twenty":-19.875402,"median":-15.51453,"eighty":-10.813365,"marketCap":6494259707},{"date":"2025-12-05","current":-9.176571,"twenty":-19.875402,"median":-15.428809,"eighty":-10.769092,"marketCap":6030851536},{"date":"2025-12-12","current":-8.881773,"twenty":-19.856979,"median":-15.337298,"eighty":-10.735643,"marketCap":5837110267},{"date":"2025-12-19","current":-8.706488,"twenty":-19.825078,"median":-15.267803,"eighty":-10.690375,"marketCap":5721912755},{"date":"2025-12-26","current":-9.491287,"twenty":-19.825078,"median":-15.226852,"eighty":-10.643534,"marketCap":6237683431},{"date":"2026-01-02","current":-9.190514,"twenty":-19.825078,"median":-15.171582,"eighty":-10.613914,"marketCap":6040014974},{"date":"2026-01-09","current":-9.02718,"twenty":-19.825078,"median":-15.141388,"eighty":-10.565682,"marketCap":5932671839},{"date":"2026-01-16","current":-9.56897,"twenty":-19.825078,"median":-15.056803,"eighty":-10.48168,"marketCap":6288736874},{"date":"2026-01-23","current":-10.722266,"twenty":-19.825078,"median":-15.039487,"eighty":-10.426172,"marketCap":7046684137},{"date":"2026-01-30","current":-10.521087,"twenty":-19.825078,"median":-15.022512,"eighty":-10.41063,"marketCap":6914468811},{"date":"2026-02-06","current":-11.775877,"twenty":-19.825078,"median":-15.002599,"eighty":-10.41063,"marketCap":7739118138},{"date":"2026-02-13","current":-12.00305,"twenty":-19.825078,"median":-14.938572,"eighty":-10.41063,"marketCap":7888416651},{"date":"2026-02-20","current":-12.520743,"twenty":-19.825078,"median":-14.868084,"eighty":-10.41063,"marketCap":8228644995},{"date":"2026-02-27","current":-11.263901,"twenty":-19.825078,"median":-14.836493,"eighty":-10.41063,"marketCap":8635221660},{"date":"2026-03-06","current":-10.93537,"twenty":-19.825078,"median":-14.789855,"eighty":-10.41063,"marketCap":8383361028},{"date":"2026-03-13","current":-10.552398,"twenty":-19.825078,"median":-14.736275,"eighty":-10.41063,"marketCap":8089763491},{"date":"2026-03-20","current":-10.133756,"twenty":-19.825078,"median":-14.633932,"eighty":-10.387838,"marketCap":7768821086},{"date":"2026-03-27","current":-10.2708,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"marketCap":7873882950},{"date":"2026-04-02","current":-10.982303,"twenty":-19.825078,"median":-14.631091,"eighty":-10.355291,"marketCap":8419341118},{"date":"2026-04-10","current":-11.581167,"twenty":-19.825078,"median":-14.631091,"eighty":-10.355291,"marketCap":8878447070},{"date":"2026-04-17","current":-11.67691,"twenty":-19.825078,"median":-14.631091,"eighty":-10.355291,"marketCap":8951846454},{"date":"2026-04-24","current":-11.408454,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"marketCap":8746040337},{"date":"2026-05-01","current":-10.780619,"twenty":-19.825078,"median":-14.631091,"eighty":-10.364849,"marketCap":8264724759},{"date":"2026-05-08","current":-7.852935,"twenty":-19.825078,"median":-14.631091,"eighty":-10.387838,"marketCap":7433054343},{"date":"2026-05-15","current":-8.16624,"twenty":-19.825078,"median":-14.631091,"eighty":-10.359343,"marketCap":7729607917},{"date":"2026-05-22","current":-7.229556,"twenty":-19.825078,"median":-14.631091,"eighty":-10.320728,"marketCap":6843006149},{"date":"2026-05-29","current":-7.789431,"twenty":-19.83248,"median":-14.632651,"eighty":-10.272677,"marketCap":7372945642},{"date":"2026-06-05","current":-7.438556,"twenty":-19.825078,"median":-14.631091,"eighty":-10.234464,"marketCap":7040830974},{"date":"2026-06-12","current":-7.214301,"twenty":-19.825078,"median":-14.595889,"eighty":-10.172838,"marketCap":6828566381},{"date":"2026-06-18","current":-7.729935,"twenty":-19.825078,"median":-14.595889,"eighty":-10.15146,"marketCap":7316630546},{"date":"2026-06-26","current":-8.189124,"twenty":-19.83248,"median":-14.562246,"eighty":-10.071801,"marketCap":7751267569},{"date":"2026-07-02","current":-8.555254,"twenty":-19.83248,"median":-14.559871,"eighty":-10.00945,"marketCap":8097822006},{"date":"2026-07-10","current":-9.127334,"twenty":-19.83248,"median":-14.559871,"eighty":-9.979816,"marketCap":8639313314},{"date":"2026-07-17","current":-8.549152,"twenty":-19.83248,"median":-14.559871,"eighty":-9.928317,"marketCap":8092046099},{"date":"2026-07-24","current":-8.48813,"twenty":-19.83248,"median":-14.559871,"eighty":-9.864294,"marketCap":8034287026},{"date":"2026-07-31","current":-8.536948,"twenty":-19.835244,"median":-14.561058,"eighty":-9.798636,"marketCap":8080494284},{"date":"2026-08-07","current":-7.990126,"twenty":-19.835244,"median":-14.544872,"eighty":-9.695653,"marketCap":8503579492},{"date":"2026-08-14","current":-8.229822,"twenty":-19.835244,"median":-14.46995,"eighty":-9.645302,"marketCap":8758678663},{"date":"2026-08-21","current":-8.576576,"twenty":-19.835244,"median":-14.441039,"eighty":-9.528943,"marketCap":9127715752},{"date":"2026-08-28","current":-8.55071,"twenty":-19.835244,"median":-14.329338,"eighty":-9.491287,"marketCap":9100186776},{"date":"2026-09-04","current":-8.552807,"twenty":-19.835244,"median":-14.136416,"eighty":-9.416638,"marketCap":9102418855},{"date":"2026-09-10","current":-8.320705,"twenty":-19.835244,"median":-14.098831,"eighty":-9.361951,"marketCap":8855402093}],"updateTime":1789126018117},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCVX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640892345","title":"Vaxcyte Doses First Participant in Phase 1 Study Evaluating Vax-a1 for the Prevention of Disease Caused by Group a Streptococcus in Healthy Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2640892345","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640892345?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:05","pubTimestamp":1780430701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nTUA3C03JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009354923.USD","BK4139","PCVX","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638519212","title":"S&P 500 Futures Climb In Premarket Trading; MDA Space, ViaSat Lead","url":"https://stock-news.laohu8.com/highlight/detail?id=2638519212","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638519212?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:30","pubTimestamp":1779795000,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Barrons.com using technology from Automated Insights.With U.S. stock markets set to open in two hours, MDA Space Ltd.  was up 17.8% in pre-market trading, and ViaSat Inc.  was up 15.7%.Modine Manufacturing Co. , Vaxcyte Inc. , and Intuitive Machines Inc. Cl A  were all posting gains of at least 11%. In early trading, AutoZone Inc.  and CGI Inc. Cl A  had posted declines, falling 5.6% and 4.1%, respectively.Meanwhile S&P 500 futures were up 0.68%, with futures for the Dow Jones Industrial Average rising 0.59%. The Cboe Volatility Index futures were up 1.29%.In commodities news, Brent crude oil futures were up 2.46%, and gold futures were up 0.15%. Bitcoin fell 0.29% to $77,163.In the previous regular trading session, the S&P 500 and the Dow were up 0.37% and 0.58%, respectively. Stocks in Asia were down overnight, with Japan's NIKKEI 225 Index down 0.25% and China's Shanghai Composite Index falling 0.17%.U.S. stock markets open for trading at ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455863.HKD","SPMO","VTI","LU1196500208.SGD","BK4214","BK4020","RSPU","SPXL","LU2065731478.USD","SPYM","ACWI","MMAX","SH","VV","SPDN","SPXS","LU0965508806.USD","LU0314106906.USD","SPUU","SPYU","SPLV","LU0965509010.AUD","RSPN",".SPX","BK4124","LU1221951129.SGD","SPYG","SCHB","IVE","LU1506573853.SGD","RSPA","NOBL","ALLW","SPYD","SPYV","BK4139","GPIX","BK4134","RSP","LU0965509101.SGD","SPHD","LUNR","LU0861579265.USD","SPUS","VBK","LU1934455194.USD","SSO","SPHQ","LU1037948541.HKD","LU1571399168.USD","SPYH","LU0345770993.USD","SMAX","MOAT","MDALF","IVW","VXX","IE0009354923.USD","BK4588","IJH","LUNL","SPYQ","BK4602","DBSC","GSLC","PCVX","SDS","SCHX","AZO","HIBL","XYLD","DMAX","BK4086","XDTE","VSAT","LU1221951046.USD","IE00B7SZL793.SGD","TSPY","BK4511","LU2463526074.USD","JEPI","HIBS","YSPY","BMAY","SPXU","LU0234570918.USD","ITOT","UPRO","SFY","LU0965509283.SGD","VTV","XLG","VEU","IE0031619046.USD","SPGP","IJR","LU0053666078.USD","GIB","BK4585","IVV","LU1934455277.USD","IE00B66KJ199.SGD","LU1037948897.HKD","LU1032955483.USD","LU0053671581.USD","MOD","IE00B19Z4B17.USD","ETFT","LU0345770308.USD","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633091178","title":"Vaxcyte Down Over 10%, On Track for Largest Percent Decrease Since May 2025 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2633091178","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633091178?lang=en_us&edition=fundamental","pubTime":"2026-05-08 03:03","pubTimestamp":1778180580,"startTime":"0","endTime":"0","summary":"Vaxcyte, Inc.  is currently at $51.12, down $5.98 or 10.47%. --Would be lowest close since Jan. 21, 2026, when it closed at $50.22. --On pace for largest percent decrease since May 6, 2025, when it fell 14.7%. --Down 56.65% from its all-time closing high of $117.93 on Oct. 16, 2024. --Up 62.54% from 52 weeks ago , when it closed at $31.45. --Up 73.76% from its 52-week closing low of $29.42 on May 14, 2025. --Traded as low as $48.49; lowest intraday level since Jan. 21, 2026, when it hit $46.92. --Down 15.08% at today's intraday low; largest intraday percent decrease since April 1, 2025, when it fell as much as 15.82%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4139","LU0053671581.USD","PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633812721","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmaceuticals (ACAD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633812721","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633812721?lang=en_us&edition=fundamental","pubTime":"2026-05-08 01:40","pubTimestamp":1778175631,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Evotec AG (EVO), Vaxcyte (PCVX) and ACADIA Pharmac...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-evotec-ag-evo-vaxcyte-pcvx-and-acadia-pharmaceuticals-acad-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-evotec-ag-evo-vaxcyte-pcvx-and-acadia-pharmaceuticals-acad-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AG","LU2065169927.USD","BK4137","XBI","BK4139","XLV","HCSG","LABU","BK4588","LU2065171402.SGD","EVO","LU2065170008.USD","BK4121","LU2065171311.SGD","IE0009354923.USD","ACAD","BK4581","BK4585","PCVX","BK4210","LU0029874061.USD","LU0053671581.USD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633227157","title":"Vaxcyte Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633227157","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633227157?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:49","pubTimestamp":1778100565,"startTime":"0","endTime":"0","summary":"Vaxcyte Inc reports results for the quarter ended December 31 - Earnings SummaryVaxcyte Inc PCVX.OQ reported a quarterly adjusted loss of $1.80 per share for the quarter ended December 31, lower than ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nL8N41J3IE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","PCVX","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633152082","title":"Vaxcyte Q1 EPS $(2.30) Misses $(1.82) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2633152082","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633152082?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:35","pubTimestamp":1778099740,"startTime":"0","endTime":"0","summary":"Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(2.30) per share which missed the analyst consensus estimate of $(1.82) by 26.37 percent. This is a 121.15 percent decrease over losses of $(1.04) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52346535/vaxcyte-q1-eps-2-30-misses-1-82-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte Q1 EPS $(2.30) Misses $(1.82) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633115423","title":"Vaxcyte Q1 net loss widens to $320.6 million; R&D expenses jump to $312.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633115423","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633115423?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:20","pubTimestamp":1778098808,"startTime":"0","endTime":"0","summary":"Vaxcyte posted a net loss of USD 320.6 million for first-quarter 2026, widening from USD 140.7 million a year earlier, while R&D expense more than doubled to USD 312.8 million.Cash, cash equivalents and investments rose to USD 2.74 billion as of March 31, 2026 from USD 2.44 billion at year-end 2025, including USD 601.8 million in net proceeds from a February equity offering.Enrollment is now complete across OPUS-1, OPUS-2 and OPUS-3 Phase 3 adult trials of VAX-31, with 6,191 adults dosed; OPUS-1 topline safety, tolerability and immunogenicity data are expected in fourth-quarter 2026.Management said it remains on track for planned BLA submission and potential U.S. commercial launch, with a Phase 1 adult study for Group A Strep candidate VAX-A1 slated to start in mid-2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL2WVk0J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BN0W2T93.GBP","LU0314104364.USD","NDAQ","IE00BGHQF748.EUR","IE00BN0W2W23.USD","PCVX","IE00B64PRP62.GBP","SG9999014021.USD","LU0053671581.USD","SG9999014005.SGD","BK4585","SG9999014039.USD","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","LU2210150020.SGD","BK4112","IE00BN0W2V16.EUR","SG9999014013.SGD","LU2210149790.SGD","BK4139","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633937151","title":"BRIEF-Vaxcyte Q1 Operating Expenses USD 345.85 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633937151","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633937151?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:05","pubTimestamp":1778097946,"startTime":"0","endTime":"0","summary":"BRIEF-Vaxcyte Q1 Operating Expenses USD 345.85 Million\n\n\nMay 06 (Reuters) - Vaxcyte Q1 net income USD -320.622 million vs. IBES estimate USD -256.4 million.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nPLXDEBE82:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX","IE0009354923.USD","LU0053671581.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632628470","title":"Vaxcyte COO Jim Wassil disposes of USD 127,869 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2632628470","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632628470?lang=en_us&edition=fundamental","pubTime":"2026-05-02 05:38","pubTimestamp":1777671524,"startTime":"0","endTime":"0","summary":"Vaxcyte Chief Operating Officer Jim Wassil sold 2,250 common shares on May 1, 2026.Sale priced at USD 56.83 per share on weighted-average basis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 01, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL5gVlfS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte COO Jim Wassil disposes of USD 127,869 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX","BK4139","IE0009354923.USD","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629683718","title":"Vaxcyte announces upcoming annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2629683718","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629683718?lang=en_us&edition=fundamental","pubTime":"2026-04-24 04:11","pubTimestamp":1776975064,"startTime":"0","endTime":"0","summary":"Vaxcyte schedules virtual annual stockholder meeting for June 15, 2026.Stockholders will vote to elect three Class III directors to serve until 2029.Meeting agenda includes ratification of Deloitte & Touche as independent registered public accounting firm for fiscal 2026.Advisory vote planned on compensation for named executive officers.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 23, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL6yv2r2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","BK4139","PCVX","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627285686","title":"Analysts Conflicted on These Healthcare Names: Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and Vaxcyte (PCVX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627285686","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627285686?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:40","pubTimestamp":1776249615,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Rocket Pharmaceuticals (RCKT), Merit Medical Systems (MMSI) and V...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-merit-medical-systems-mmsi-and-vaxcyte-pcvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-rocket-pharmaceuticals-rckt-merit-medical-systems-mmsi-and-vaxcyte-pcvx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0053671581.USD","RCKT","LABU","MMSI","IE0009354923.USD","LU0029874061.USD","XLV","BK4198","PCVX","LU1559883803.SGD","LU0566484027.USD","HCSG","BK4137","BK4139","LU0128526141.USD","BK4588","BK4585","XBI","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626922799","title":"Vaxcyte SVP Finance Elvia Cowan disposes of USD 180,000 common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2626922799","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626922799?lang=en_us&edition=fundamental","pubTime":"2026-04-09 04:33","pubTimestamp":1775680405,"startTime":"0","endTime":"0","summary":"Vaxcyte SVP, Finance & CAO Elvia Cowan sold 3,000 shares on April 7 at USD 60.She exercised options for 3,000 shares on April 7 at USD 25.92.Directly held common stock position stood at 28,975 shares following transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDLbVTVkN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte SVP Finance Elvia Cowan disposes of USD 180,000 common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","PCVX","IE0009354923.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625696516","title":"Vaxcyte to present at Needham Virtual Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2625696516","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625696516?lang=en_us&edition=fundamental","pubTime":"2026-04-08 04:06","pubTimestamp":1775592391,"startTime":"0","endTime":"0","summary":"Vaxcyte management will join a fireside chat at Needham 25th Annual Virtual Healthcare Conference on April 14, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL7B3RCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","PCVX","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","SG9999014013.SGD","SG9999014021.USD","SG9999014039.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","NDAQ","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2095319765.USD","IE0009354923.USD","SG9999014005.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","LU0053671581.USD","LU2210150020.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625611939","title":"Vaxcyte (PCVX) Valuation Check As VAX-31 Phase 3 OPUS Trials Reach Full Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=2625611939","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625611939?lang=en_us&edition=fundamental","pubTime":"2026-04-05 02:14","pubTimestamp":1775326450,"startTime":"0","endTime":"0","summary":"Vaxcyte (PCVX) recently reported full enrollment in its OPUS-1 and OPUS-2 Phase 3 trials for VAX-31, a key step toward a potential Biologics License Application that investors often monitor closely.\nSee our latest analysis for Vaxcyte.\nThe recent completion of enrollment in the OPUS-1 and OPUS-2 trials comes alongside strong momentum, with a 90 day share price return of 25.66% and a 1 year total shareholder return of 84.75%, while the latest share price stands at US$58.38.\nIf this kind of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-valuation-check-as-vax-31-phase-3-opus-trials-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/vaxcyte-pcvx-valuation-check-as-vax-31-phase-3-opus-trials-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0053671581.USD","OPUS","IE0009354923.USD","BK4139","PCVX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624664866","title":"Vaxcyte COO Jim Wassil disposes of common shares worth $0.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624664866","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624664866?lang=en_us&edition=fundamental","pubTime":"2026-04-04 04:06","pubTimestamp":1775246806,"startTime":"0","endTime":"0","summary":"Vaxcyte COO Jim Wassil sold 2,250 shares on April 1, 2026.Sales totaled about $0.1 million at weighted-average prices of $58.14 and $58.93 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vaxcyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL1S98yJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Vaxcyte COO Jim Wassil disposes of common shares worth $0.1 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX","IE0009354923.USD","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622078867","title":"Vera Therapeutics appoints Jane Wright-Mitchell chief legal officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2622078867","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622078867?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:30","pubTimestamp":1774438229,"startTime":"0","endTime":"0","summary":"Vera Therapeutics appointed Jane Wright-Mitchell as Chief Legal Officer, effective immediately.Wright-Mitchell previously served as a fractional general counsel supporting public and private life sciences companies.Her prior roles include General Counsel, Chief Compliance Officer and Corporate Secretary at Vaxcyte, and Chief Legal Officer positions at other pharmaceutical and research companies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL5FDKSy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU2210149790.SGD","IE00BKPKM429.USD","LU2095319765.USD","VERA","SG9999014021.USD","IE0009354923.USD","BK4139","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","BK4112","IE00BN0W2W23.USD","IE00BN0W2T93.GBP","BK4588","LU2324357040.USD","NDAQ","IE00B64PRP62.GBP","BK4539","BK4585","SG9999014005.SGD","LU0053671581.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","PCVX","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621970553","title":"Vaxcyte completes enrollment in OPUS-1 and OPUS-2 Phase 3 trials of VAX-31 in about 5,300 adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2621970553","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621970553?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:31","pubTimestamp":1774269076,"startTime":"0","endTime":"0","summary":"Vaxcyte reported that enrollment is complete in the OPUS-1 Phase 3 trial of VAX-31 with about 4,000 participants and the OPUS-2 Phase 3 trial with about 1,300 participants.OPUS-1 is a randomized, double-blind, active-controlled noninferiority study comparing VAX-31 with Capvaxive  and Prevnar 20  in pneumococcal-nave adults ages 50 and older, with a separate cohort ages 18–49.Participants ages 50 and older were randomized 1:1:1 to VAX-31, PCV21, or PCV20, while adults ages 18–49 were randomized 3:1 to VAX-31 or PCV20.Topline safety, tolerability, and immunogenicity results from OPUS-1 are expected in the fourth quarter of 2026.OPUS-2 is evaluating concomitant administration of VAX-31 with a seasonal influenza vaccine, with results expected in the first half of 2027.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL2YY9Xl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","LU2095319765.USD","IE0009354923.USD","LU0314104364.USD","BK4588","IE00BKPKM429.USD","SG9999014039.USD","PCVX","BK4139","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BK4585","NDAQ","SG9999014013.SGD","LU0053671581.USD","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621055337","title":"Vaxcyte Inc - Opus-3 Phase 3 Results Expected in First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2621055337","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621055337?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269001,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nTUA1RWLJ1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","PCVX","LU0053671581.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621670562","title":"Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2621670562","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621670562?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:30","pubTimestamp":1774269000,"startTime":"0","endTime":"0","summary":"OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with Capva","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/23/3260381/0/en/Vaxcyte-Completes-Enrollment-of-OPUS-1-and-OPUS-2-Phase-3-Trials-Evaluating-VAX-31-for-the-Prevention-of-Invasive-Pneumococcal-Disease-and-Pneumonia-in-Adults.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU0868494617.USD","IE00BSNM7G36.USD","BK4196","LU0053671581.USD","IE0002270589.USD","CI","LB","BK4139","LU0058720904.USD","PCVX","BK4233","BK4585","OPUS","IE0009354923.USD","LU1261432733.SGD","BK4588","LU1169590202.USD","LU0289739699.SGD","LU1059921491.USD","BK4213","IE00B19Z3581.USD","LU1169589451.USD","PD","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621718060","title":"Will VAX-31’s Phase 3 OPUS Progress and Broader Serotype Coverage Change Vaxcyte’s (PCVX) Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2621718060","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621718060?lang=en_us&edition=fundamental","pubTime":"2026-03-22 10:12","pubTimestamp":1774145542,"startTime":"0","endTime":"0","summary":"Vaxcyte recently reported in The Lancet Infectious Diseases that its 31-valent pneumococcal conjugate vaccine candidate VAX-31 showed strong immune responses and a safety profile similar to Prevnar 20 in a Phase 1/2 study of 1,015 adults aged 50 and older, and has since advanced the high-dose regimen into the OPUS Phase 3 adult program.\nAn important insight from these data is that VAX-31 met or exceeded regulatory immunogenicity criteria for all 31 serotypes at higher doses while covering...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/will-vax-31s-phase-3-opus-progress-and-broader-serotype-cove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pcvx/vaxcyte/news/will-vax-31s-phase-3-opus-progress-and-broader-serotype-cove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE0009354923.USD","PRGS","BK4139","OPUS","LU2065732104.USD","BK4097","LU0053671581.USD","PCVX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":66,"code":"91000000","status":"200"}]}}